Literature DB >> 21873325

Recent clinical history and cognitive dysfunction for attention and executive function among human immunodeficiency virus-infected patients.

David F Tate1, Allison Delong, Daniel E McCaffrey, Kinga Kertesz, Robert H Paul, Jared Conley, Troy Russell, Kathleen Coop, Fizza Gillani, Timothy Flanigan, Karen Tashima, Joseph W Hogan.   

Abstract

This study examined the association between recent trends in CD4 and viral loads and cognitive test performance with the expectation that recent history could predict cognitive performance. Eighty-three human immunodeficiency virus (HIV)-infected patients with a mean CD4 count of 428 copies/ml were examined in this study (62% with undetectable plasma viral load [PVL]). We investigated the relationships between nadir CD4 cell count, 1-year trends in immunologic function/PVLs, and cognitive performance across several domains using linear regression models. Nadir CD4 cell count was predictive of current executive function (p = .004). One year clinical history for CD4 cell counts and/or PVLs were predictive of executive function, attention/working memory, and learning/memory measures (p < .05). Models that combined recent clinical history trends and nadir CD4 cell counts suggested that recent clinical trends were more important in predicting current cognitive performance for all domains except executive function. This research suggests that recent CD4 and viral load history is an important predictor of current cognitive function across several cognitive domains. If validated, clinical variables and cognitive dysfunction models may improve our understanding of the dynamic relationships between disease evolution and progression and CNS involvement.

Entities:  

Mesh:

Year:  2011        PMID: 21873325      PMCID: PMC3243921          DOI: 10.1093/arclin/acr065

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  43 in total

1.  Preliminary validity of "integneuro": a new computerized battery of neurocognitive tests.

Authors:  Robert H Paul; Jeffrey Lawrence; Leanne M Williams; C Clark Richard; Nicholas Cooper; Evian Gordon
Journal:  Int J Neurosci       Date:  2005-11       Impact factor: 2.292

Review 2.  Dementia and neurocognitive disorders due to HIV-1 infection.

Authors:  Beau M Ances; Ronald J Ellis
Journal:  Semin Neurol       Date:  2007-02       Impact factor: 3.420

3.  A comparison of smoothing techniques for CD4 data measured with error in a time-dependent Cox proportional hazards model.

Authors:  P Bycott; J Taylor
Journal:  Stat Med       Date:  1998-09-30       Impact factor: 2.373

4.  Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection--The Hawaii Aging with HIV Cohort.

Authors:  Victor Valcour; Priscilla Yee; Andrew E Williams; Bruce Shiramizu; Michael Watters; Ola Selnes; Robert Paul; Cecilia Shikuma; Ned Sacktor
Journal:  J Neurovirol       Date:  2006-10       Impact factor: 2.643

5.  Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.

Authors:  Justin C McArthur; Michael P McDermott; Daniel McClernon; Coryse St Hillaire; Kathy Conant; Karen Marder; Giovanni Schifitto; Ola A Selnes; Ned Sacktor; Yaakov Stern; Steve M Albert; Karl Kieburtz; Joy A deMarcaida; Bruce Cohen; Leon G Epstein
Journal:  Arch Neurol       Date:  2004-11

6.  Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.

Authors:  N Sacktor; N Nakasujja; R Skolasky; K Robertson; M Wong; S Musisi; A Ronald; E Katabira
Journal:  Neurology       Date:  2006-07-25       Impact factor: 9.910

7.  Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy.

Authors:  E A Childs; R H Lyles; O A Selnes; B Chen; E N Miller; B A Cohen; J T Becker; J Mellors; J C McArthur
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

8.  Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort.

Authors:  Valerio Tozzi; Pietro Balestra; Patrizia Lorenzini; Rita Bellagamba; Simonetta Galgani; Angela Corpolongo; Chrysoula Vlassi; Dora Larussa; Mauro Zaccarelli; Pasquale Noto; Ubaldo Visco-Comandini; Marinella Giulianelli; Giuseppe Ippolito; Andrea Antinori; Pasquale Narciso
Journal:  J Neurovirol       Date:  2005-07       Impact factor: 2.643

Review 9.  Neurological complications of HIV infection.

Authors:  Justin C McArthur; Bruce J Brew; Avi Nath
Journal:  Lancet Neurol       Date:  2005-09       Impact factor: 44.182

10.  HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.

Authors:  J Allen McCutchan; Julia W Wu; Kevin Robertson; Susan L Koletar; Ronald J Ellis; Susan Cohn; Michael Taylor; Steven Woods; Robert Heaton; Judith Currier; Paige L Williams
Journal:  AIDS       Date:  2007-05-31       Impact factor: 4.177

View more
  7 in total

1.  The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals.

Authors:  Sapna M Patel; April D Thames; Natalie Arbid; Stella E Panos; Steven Castellon; Charles H Hinkin
Journal:  J Clin Exp Neuropsychol       Date:  2013-04-03       Impact factor: 2.475

2.  The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairment.

Authors:  María J Marquine; Anya Umlauf; Alexandra S Rooney; Pariya L Fazeli; Ben D Gouaux; Steven Paul Woods; Scott L Letendre; Ronald J Ellis; Igor Grant; David J Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2014-02-01       Impact factor: 3.731

3.  Basal ganglia shrinkage without remarkable hippocampal atrophy in chronic aviremic HIV-positive patients.

Authors:  Tamara Tesic; Jasmina Boban; Mladen Bjelan; Aleksandar Todorovic; Dusko Kozic; Snezana Brkic
Journal:  J Neurovirol       Date:  2018-04-23       Impact factor: 2.643

4.  Learning and Memory in Children and Adolescents With Perinatal HIV Infection and Perinatal HIV Exposure.

Authors:  Sharon L Nichols; Miriam C Chernoff; Kathleen Malee; Patricia A Sirois; Paige L Williams; Veronica Figueroa; Steven P Woods
Journal:  Pediatr Infect Dis J       Date:  2016-06       Impact factor: 2.129

Review 5.  The Aging Brain With HIV Infection: Effects of Alcoholism or Hepatitis C Comorbidity.

Authors:  Natalie M Zahr
Journal:  Front Aging Neurosci       Date:  2018-03-22       Impact factor: 5.750

6.  East African HIV care: depression and HIV outcomes.

Authors:  S M Meffert; T C Neylan; C E McCulloch; L Maganga; Y Adamu; F Kiweewa; J Maswai; J Owuoth; C S Polyak; J A Ake; V G Valcour
Journal:  Glob Ment Health (Camb)       Date:  2019-05-31

7.  Association between Veterans Aging Cohort Study (VACS) index and neurocognitive function among people living with HIV-a cross sectional study in coastal South India.

Authors:  Archana Ganapathy; Basavaprabhu Achappa; Vaman Kulkarni; Deepak Madi; Ramesh Holla; Unnikrishnan Bhaskaran; Priya Rathi; Soundarya Mahalingam; Nikhil Victor Dsouza
Journal:  AIDS Res Ther       Date:  2021-08-04       Impact factor: 2.250

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.